Concord Drugs standalone net profit rises 30.77% in the June 2020 quarter
Sales rise 36.74% to Rs 18.20 crore
Net profit of Concord Drugs rose 30.77% to Rs 0.17 crore in the quarter ended June 2020 as against Rs 0.13 crore during the previous quarter ended June 2019. Sales rose 36.74% to Rs 18.20 crore in the quarter ended June 2020 as against Rs 13.31 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales18.2013.31 37 OPM %5.277.06 -PBDT0.540.54 0 PBT0.220.18 22 NP0.170.13 31Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 15 2020 | 10:09 AM IST